INVOKANA® site map Home MOA CV risk reduction A1C, body weight, & SBP early results - monotherapy study long-term results SGLT2i network meta-analysis safety profile long-term safety results, including eGFR monotherapy safety results SGLT2i network meta-analysis dosing access & support support coverage finder patient resources live events & FAQs virtual speaker events FAQs testimonials